Canada Sees Face-Off Over Higher-Strength Adalimumab
Jamp And Alvotech Go Head-To-Head With Celltrion On 100mg/ml Biosimilar Humira
Hot on the heels of rival Celltrion, Jamp and partner Alvotech have now launched their own higher-strength adalimumab biosimilar in Canada, setting up a showdown between their Simlandi version and Celltrion’s Yuflyma.
